The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer

Distinct Metastatic Phenotypes Between Early-onset and Late-onset Colorectal Cancer

NCT06040021 ·Status: COMPLETED

The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey

NCT01549067 ·Status: UNKNOWN

Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

NCT03573791 ·Status: RECRUITING

Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer

NCT03532711 ·Status: COMPLETED

Application of MR-PET in Colorectal Cancer

NCT02553031 ·Status: UNKNOWN

Individual Dosage Selection of Irinotecan (CPT-11) Based on UGT1A1 Genotype in Metastatic Colorectal Cancer Patients

NCT01523431 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer

NCT03142282 ·Status: UNKNOWN ·Phase: PHASE2

High-activity Natural Killer Immunotherapy for Small Metastases of Colorectal Cancer

NCT03008499 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

MDT to Evaluate the Survival Benefit of Patients With Advanced Gastric / Colorectal Cancer

NCT03400657 ·Status: UNKNOWN

Metabolism Imaging-genomics for Predicting the Surgical Outcomes of Colorectal Cancer

NCT06614660 ·Status: ACTIVE_NOT_RECRUITING

Translational Research in Identifying Molecular Mechanisms for Rectal Cancer Metastasis

NCT02979795 ·Status: UNKNOWN

Microwave Ablation for Pulmonary Metastases From Colorectal Cancer

NCT02502630 ·Status: COMPLETED ·Phase: NA

PET-CT and Circulating Tumor Cells in Colorectal Cancer

NCT01163305 ·Status: COMPLETED

Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis

NCT02453490 ·Status: TERMINATED ·Phase: PHASE3

The Value of ctDNA on Chemotherapy Efficacy for mCRC

NCT04555369 ·Status: UNKNOWN ·Phase: NA

A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study

NCT05600309 ·Status: COMPLETED ·Phase: PHASE3

Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence

NCT06120127 ·Status: RECRUITING ·Phase: PHASE2

Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial

NCT05755685 ·Status: UNKNOWN ·Phase: PHASE2

Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1

NCT02605265 ·Status: COMPLETED ·Phase: PHASE3

Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases

NCT01677728 ·Status: UNKNOWN

Molecular Study and Precision Medicine for Colorectal Cancer

NCT05883683 ·Status: NOT_YET_RECRUITING

Constructing a Multimodal Imaging System to Predict the Risk of Heterochronous Metastasis of Rectal Cancer

NCT06293612 ·Status: COMPLETED

Using ctDNA Methylation to Monitor Metastatic Colorectal Cancer Treatment (PROMET)

NCT07283575 ·Status: RECRUITING

Nutritional Psychological Intervention and Vomit-free Management on Survival and Quality of Life in Advanced Gastrointestinal Tumors

NCT06223230 ·Status: RECRUITING ·Phase: NA

Tislelizumab Combined With Fruquintinib and SBRT as Athird-line and Posterior Line Treatment in Patients With Advanced CRC

NCT04924179 ·Status: UNKNOWN ·Phase: PHASE2